20474. EL SWITCH DE ANTI-CGRP EN MIGRAÑA PUEDE BENEFICIAR A UN 25% DE LOS PACIENTES QUE NO RESPONDEN AL PRIMER FÁRMACO: ESTUDIO RETROSPECTIVO DE 82 CASOS

{"title":"20474. EL SWITCH DE ANTI-CGRP EN MIGRAÑA PUEDE BENEFICIAR A UN 25% DE LOS PACIENTES QUE NO RESPONDEN AL PRIMER FÁRMACO: ESTUDIO RETROSPECTIVO DE 82 CASOS","authors":"A. Muñoz Vendrell, S. Campoy, J. Campdelacreu, L. Termens, J. Prat, M. Huerta Villanueva","doi":"10.1016/S2667-0496(24)00065-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":74283,"journal":{"name":"Neurology perspectives","volume":"4 ","pages":"Page 9"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology perspectives","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667049624000656","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}